Northwest Biotherapeutics

From WikiMD's WELLNESSPEDIA

Northwest Biotherapeutics (also known as NW Bio) is a biotechnology company that specializes in the development of immunotherapy products to treat cancer. The company was founded in 1996 and is headquartered in Bethesda, Maryland, United States.

History[edit]

Northwest Biotherapeutics was established in 1996 with the aim of developing novel therapeutic approaches to treat cancer. The company's primary focus is on the development of personalized immunotherapy treatments that utilize a patient's own immune system to fight cancer.

Products and Research[edit]

Northwest Biotherapeutics' lead product, DCVax-L, is a personalized vaccine designed to stimulate an immune response against cancer cells. DCVax-L is currently in clinical trials for the treatment of glioblastoma, a type of brain cancer.

In addition to DCVax-L, the company is also developing DCVax-Direct, a product designed for the treatment of inoperable solid tumors. This product is also currently in clinical trials.

Clinical Trials[edit]

The company's products are in various stages of clinical trials. The most advanced of these is DCVax-L, which is in Phase III clinical trials for the treatment of newly diagnosed glioblastoma. The company has also initiated a Phase I/II trial for DCVax-Direct for the treatment of inoperable solid tumors.

Financials[edit]

As a publicly traded company, Northwest Biotherapeutics' financial performance is a matter of public record. The company is listed on the NASDAQ stock exchange under the ticker symbol "NWBO".

See Also[edit]


This biotechnology company-related article is a stub.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Northwest_Biotherapeutics&oldid=6616427"